CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers - Poll - MDSpire

CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers

  • By

  • Junhao Cui

  • Yanchuan Zhang

  • Yongfang Wu

  • Guangjie Zhang

  • Jie Lan

  • Yingshuang Wang

  • June 4, 2026

  • 0 min

Share

Original Source(s)

CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers

  • by Junhao Cui, Yanchuan Zhang, Yongfang Wu, Guangjie Zhang, Jie Lan, Yingshuang Wang

  • June 4, 2026

Related Content

What RevMed’s pancreatic cancer drug meant for one patient

Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma